As digital technology and the online environment transform the distribution and use of intellectual property, our Copyright & Trademark group is on the front lines in protecting and enforcing our clients’ most important creative assets. Our trial-tested team represents a wide range of clients, from entrepreneurs to major corporations, from playwrights to media giants, and from individual songwriters to the country’s largest performing rights organizations.
Intellectual Property Litigation - Doctrine of Equivalents, Drug Name Confusion, Privilege
June 21, 2004 Full PDF
The June 21 edition of the New York Law Journal features an article written by Lewis Clayton entitled, "Doctrine of Equivalents, Drug Name Confusion, Privilege." The article analyzes a recent Court of Appeals for the Federal Circuit en banc opinion on the doctrine of equivalents in patent law, Honeywell International Inc. v. Hamilton Sundstrand Corp. Lew indicates that the Honeywell decision is likely to limit the permissible range of equivalents for thousands of issued patents that include rewritten dependent claims. The article also discusses other significant recent patent, copyright and trademark cases. Susanna Buergel assisted in the preparation of this article.